Dyadic International (DYAI)

$0.87 -0.04 (-3.87%)
Market Cap 32.75M
Revenue (ttm) 3.50M
Net Income (ttm) -5.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -166.00%
Debt to Equity Ratio 0.00
Volume 40,100
Avg Vol 251,428
Day's Range N/A - N/A
Shares Out 36.19M
Stochastic %K 21%
Beta 1.26
Analysts Strong Sell
Price Target $7.00

Company Profile

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products f...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 743 8333
Fax: 561 743 8343
Address:
1044 North U.S. Highway One, Suite 201, Jupiter, United States
Buster1965
Buster1965 Jan. 29 at 7:31 PM
$DYAI Compression before move
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 4:06 PM
$DYAI RSI: 42.86, MACD: -0.0150 Vol: 0.04, MA20: 0.92, MA50: 0.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
AyoRee
AyoRee Jan. 15 at 3:11 AM
$ANY $PRPL $PMCB $DYAI Lets make some money!
2 · Reply
BillionerOfKing
BillionerOfKing Jan. 7 at 7:53 PM
$DYAI Current Stock Price: $0.96 Contracts to trade: $2.5 DYAI Feb 20 2026 Call Entry: $0.09 Exit: $0.15 ROI: 70% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 31 at 1:51 AM
$DYAI Share Price: $0.88 Contract Selected: May 15, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 71% ROI Time to Expiration: 135 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
RhoRealm
RhoRealm Dec. 25 at 4:12 PM
$DYAI Volatility reflects uncertainty about how effectively strategy converts into measurable outcomes. Competitive differentiation needs clearer proof points. Evidence of resilience during turbulence would be constructive. In short, this remains an execution‑driven story with meaningful but conditional upside.
0 · Reply
ZacksSCR
ZacksSCR Dec. 23 at 2:11 PM
$DYAI Layers of Commercialization Agreements https://buff.ly/zQtanwA
0 · Reply
Jbaffs
Jbaffs Dec. 19 at 6:03 PM
$DYAI $1.50 In January
0 · Reply
iAccess_Alpha
iAccess_Alpha Dec. 19 at 1:42 PM
Did you miss $DYAI’s presentation? Replays are still available from iAccess Alpha’s Virtual Best Ideas Winter Conference. Watch here: https://www.webcaster5.com/Webcast/Page/3148/53193 #microcap #smallcap #investing
0 · Reply
Glopolon
Glopolon Dec. 17 at 2:27 PM
$DYAI Really good news, but everyone knows not to buy premarket now. https://seekingalpha.com/pr/20342410-dyadic-and-fermbox-bio-expand-strategic-collaboration-to-accelerate-commercialization-of
0 · Reply
Latest News on DYAI
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins

Dec 15, 2025, 7:20 AM EST - 6 weeks ago

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dec 9, 2025, 10:57 AM EST - 7 weeks ago

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

Dec 1, 2025, 7:25 AM EST - 2 months ago

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 9:01 PM EST - 2 months ago

Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

Nov 12, 2025, 4:05 PM EST - 2 months ago

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Oct 29, 2025, 7:25 AM EDT - 3 months ago

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Oct 6, 2025, 8:30 AM EDT - 4 months ago

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Dyadic to Present at Investor Conferences and BPI East

Sep 4, 2025, 9:00 AM EDT - 5 months ago

Dyadic to Present at Investor Conferences and BPI East

Dyadic International, Inc. (DYAI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 7:51 PM EDT - 6 months ago

Dyadic International, Inc. (DYAI) Q2 2025 Earnings Call Transcript

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Aug 13, 2025, 4:01 PM EDT - 6 months ago

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Aug 5, 2025, 4:11 PM EDT - 6 months ago

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Jul 31, 2025, 8:47 AM EDT - 6 months ago

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Jul 31, 2025, 7:30 AM EDT - 6 months ago

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Jul 30, 2025, 4:02 PM EDT - 6 months ago

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

Jul 2, 2025, 4:00 PM EDT - 7 months ago

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Jun 2, 2025, 8:35 AM EDT - 8 months ago

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic International, Inc. (DYAI) Q1 2025 Earnings Call Transcript

May 14, 2025, 11:31 PM EDT - 9 months ago

Dyadic International, Inc. (DYAI) Q1 2025 Earnings Call Transcript

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

May 1, 2025, 3:00 PM EDT - 9 months ago

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Dyadic to Present at World Vaccine Congress | Washington

Apr 16, 2025, 2:00 PM EDT - 10 months ago

Dyadic to Present at World Vaccine Congress | Washington

Dyadic International, Inc. (DYAI) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 10:58 PM EDT - 11 months ago

Dyadic International, Inc. (DYAI) Q4 2024 Earnings Call Transcript

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Mar 26, 2025, 4:05 PM EDT - 11 months ago

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Mar 12, 2025, 4:00 PM EDT - 11 months ago

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Dyadic to Attend Multiple Industry Events in March

Mar 6, 2025, 8:30 AM EST - 11 months ago

Dyadic to Attend Multiple Industry Events in March

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 8:30 AM EST - 1 year ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Nov 21, 2024, 8:30 AM EST - 1 year ago

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript

Nov 16, 2024, 8:16 PM EST - 1 year ago

Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Nov 4, 2024, 4:30 PM EST - 1 year ago

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Dyadic Expands Global Presence with Participation in Key Industry Events

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Dyadic Expands Global Presence with Participation in Key Industry Events

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

Sep 23, 2024, 9:50 AM EDT - 1 year ago

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 11:05 PM EDT - 1 year ago

Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

Jul 30, 2024, 4:00 PM EDT - 1 year ago

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Jun 28, 2024, 8:30 AM EDT - 1 year ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Dyadic to Attend Industry Events in June

May 30, 2024, 4:30 PM EDT - 1 year ago

Dyadic to Attend Industry Events in June

Dyadic International, Inc. (DYAI) Q1 2024 Earnings Call Transcript

May 17, 2024, 10:15 PM EDT - 1 year ago

Dyadic International, Inc. (DYAI) Q1 2024 Earnings Call Transcript

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

May 14, 2024, 4:00 PM EDT - 1 year ago

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Dyadic to Attend Industry and Investor Events in May

May 8, 2024, 8:30 AM EDT - 1 year ago

Dyadic to Attend Industry and Investor Events in May

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Apr 30, 2024, 4:30 PM EDT - 1 year ago

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 10:22 PM EDT - 2 years ago

Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Mar 28, 2024, 4:00 PM EDT - 2 years ago

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Dyadic Announces Change in Board and Management Leadership Roles

Mar 28, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Change in Board and Management Leadership Roles

Dyadic to Attend Industry Events in April

Mar 27, 2024, 8:30 AM EDT - 2 years ago

Dyadic to Attend Industry Events in April

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Mar 21, 2024, 8:30 AM EDT - 2 years ago

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

Mar 14, 2024, 4:30 PM EDT - 2 years ago

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Mar 11, 2024, 9:57 AM EDT - 2 years ago

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Mar 11, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic to Attend Industry Events in March

Mar 1, 2024, 8:30 AM EST - 2 years ago

Dyadic to Attend Industry Events in March

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Feb 28, 2024, 8:30 AM EST - 2 years ago

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Feb 23, 2024, 2:00 AM EST - 2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Feb 21, 2024, 8:30 AM EST - 2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Buster1965
Buster1965 Jan. 29 at 7:31 PM
$DYAI Compression before move
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 4:06 PM
$DYAI RSI: 42.86, MACD: -0.0150 Vol: 0.04, MA20: 0.92, MA50: 0.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
AyoRee
AyoRee Jan. 15 at 3:11 AM
$ANY $PRPL $PMCB $DYAI Lets make some money!
2 · Reply
BillionerOfKing
BillionerOfKing Jan. 7 at 7:53 PM
$DYAI Current Stock Price: $0.96 Contracts to trade: $2.5 DYAI Feb 20 2026 Call Entry: $0.09 Exit: $0.15 ROI: 70% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 31 at 1:51 AM
$DYAI Share Price: $0.88 Contract Selected: May 15, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 71% ROI Time to Expiration: 135 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
RhoRealm
RhoRealm Dec. 25 at 4:12 PM
$DYAI Volatility reflects uncertainty about how effectively strategy converts into measurable outcomes. Competitive differentiation needs clearer proof points. Evidence of resilience during turbulence would be constructive. In short, this remains an execution‑driven story with meaningful but conditional upside.
0 · Reply
ZacksSCR
ZacksSCR Dec. 23 at 2:11 PM
$DYAI Layers of Commercialization Agreements https://buff.ly/zQtanwA
0 · Reply
Jbaffs
Jbaffs Dec. 19 at 6:03 PM
$DYAI $1.50 In January
0 · Reply
iAccess_Alpha
iAccess_Alpha Dec. 19 at 1:42 PM
Did you miss $DYAI’s presentation? Replays are still available from iAccess Alpha’s Virtual Best Ideas Winter Conference. Watch here: https://www.webcaster5.com/Webcast/Page/3148/53193 #microcap #smallcap #investing
0 · Reply
Glopolon
Glopolon Dec. 17 at 2:27 PM
$DYAI Really good news, but everyone knows not to buy premarket now. https://seekingalpha.com/pr/20342410-dyadic-and-fermbox-bio-expand-strategic-collaboration-to-accelerate-commercialization-of
0 · Reply
SMARTR8
SMARTR8 Dec. 17 at 1:01 PM
$DYAI $VRAX $HIT $SXTP on watch 👀
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 17 at 12:28 PM
$DYAI Dyadic Applied BioSolutions Expands Collaboration With Fermbox Bio To Manufacture And Commercialize Animal-Free Proteins And Enzymes
0 · Reply
Glopolon
Glopolon Dec. 16 at 3:17 PM
$DYAI Short algo gets turned on anytime there is a PR, I guess.
0 · Reply
Glopolon
Glopolon Dec. 15 at 3:27 PM
$DYAI https://seekingalpha.com/pr/20339053-dyadic-applied-biosolutions-establishes-commercial-partnership-to-accelerate-adoption-of
0 · Reply
Jirish72
Jirish72 Dec. 15 at 1:11 PM
$DYAI https://stocks.apple.com/AymRz8jjnS7aWSPfHvv5mkA
0 · Reply
iAccess_Alpha
iAccess_Alpha Dec. 11 at 2:15 PM
$DYAI replay now available from iAccess Alpha’s Virtual Best Ideas Winter Conference. Replay here: https://www.webcaster5.com/Webcast/Page/3148/53193 #microcap #smallcap #investing
0 · Reply
Glopolon
Glopolon Dec. 9 at 5:01 PM
$DYAI They only need about $12M revenue with 50% + margins to break even.
0 · Reply
iAccess_Alpha
iAccess_Alpha Dec. 9 at 1:32 PM
$DYAI will be presenting today at iAccess Alpha’s Virtual Best Ideas Winter Conference. December 9, 2025 | 9:30 AM ET Watch live via Stocktwits or access the webcast here: https://www.webcaster5.com/Webcast/Page/3148/53193 #microcap #smallcap #investing
0 · Reply
iAccess_Alpha
iAccess_Alpha Dec. 8 at 2:19 PM
$DYAI will be presenting tomorrow at iAccess Alpha’s Virtual Best Ideas Winter Conference. December 9, 2025 | 9:30 AM ET Access the webcast here: https://www.webcaster5.com/Webcast/Page/3148/53193 #microcap #smallcap #investing
0 · Reply